Total Payments
$1,408
2024 Payments
$523.88
Companies
14
Transactions
72
Medicare Patients
715
Medicare Billing
$53,329
Payment Breakdown by Category
Food & Beverage$1,408 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,408 | 72 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $504.02 | 36 | $0 (2024) |
| EMD Serono, Inc. | $431.24 | 18 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $73.97 | 1 | $0 (2022) |
| Alexion Pharmaceuticals, Inc. | $63.60 | 3 | $0 (2024) |
| Biogen, Inc. | $52.96 | 3 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $49.85 | 2 | $0 (2024) |
| BOSTON SCIENTIFIC CORPORATION | $43.46 | 1 | $0 (2021) |
| Genentech USA, Inc. | $42.42 | 2 | $0 (2023) |
| BANNER LIFE SCIENCES, LLC | $28.56 | 1 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $28.33 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $523.88 | 34 | Celgene Corporation ($231.28) |
| 2023 | $572.28 | 28 | Celgene Corporation ($241.32) |
| 2022 | $244.78 | 8 | E.R. Squibb & Sons, L.L.C. ($73.97) |
| 2021 | $66.67 | 2 | BOSTON SCIENTIFIC CORPORATION ($43.46) |
All Payment Transactions
72 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $12.57 | General |
| Category: Neuroscience | ||||||
| 11/13/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $21.65 | General |
| Category: Immunology | ||||||
| 11/06/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $20.41 | General |
| Category: Neurology | ||||||
| 10/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $17.70 | General |
| Category: Neuroscience | ||||||
| 10/04/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.14 | General |
| 09/23/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $10.21 | General |
| Category: Neuroscience | ||||||
| 09/16/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $7.07 | General |
| Category: Neuroscience | ||||||
| 09/04/2024 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $17.45 | General |
| 08/28/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.44 | General |
| Category: Neuroscience | ||||||
| 08/15/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $9.94 | General |
| Category: Neuroscience | ||||||
| 07/24/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $8.18 | General |
| Category: Neuroscience | ||||||
| 07/23/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $24.14 | General |
| 07/17/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $8.25 | General |
| 07/10/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $26.93 | General |
| Category: Neuroscience | ||||||
| 07/02/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.52 | General |
| Category: Neuroscience | ||||||
| 06/26/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Rare Disease | ||||||
| 06/17/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $10.75 | General |
| Category: Neuroscience | ||||||
| 06/05/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $14.33 | General |
| Category: Neuroscience | ||||||
| 05/06/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $13.25 | General |
| Category: Neuroscience | ||||||
| 05/01/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $6.32 | General |
| Category: Neuroscience | ||||||
| 05/01/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $5.56 | General |
| Category: Neuroscience | ||||||
| 04/24/2024 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $28.10 | General |
| Category: Neurology | ||||||
| 03/22/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $27.09 | General |
| 03/19/2024 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $26.78 | General |
| 03/13/2024 | Celgene Corporation | ZEPOSIA (Drug) | Food and Beverage | Cash or cash equivalent | $6.95 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 150 | 162 | $79,752 | $14,875 |
| 2022 | 4 | 86 | 90 | $44,893 | $10,538 |
| 2021 | 2 | 51 | 52 | $8,468 | $2,656 |
| 2020 | 16 | 428 | 513 | $122,445 | $25,260 |
Total Patients
715
Total Services
817
Medicare Billing
$53,329
Procedure Codes
27
All Medicare Procedures & Services
27 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 53 | 61 | $31,415 | $5,968 | 19.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 36 | 36 | $22,752 | $3,825 | 16.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 46 | 50 | $18,400 | $3,733 | 20.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $7,185 | $1,348 | 18.8% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 42 | 42 | $24,780 | $5,670 | 22.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 17 | 17 | $8,177 | $2,109 | 25.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 13 | 13 | $5,798 | $1,433 | 24.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 14 | 18 | $6,138 | $1,325 | 21.6% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 24 | $4,778 | $1,262 | 26.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 14 | 14 | $2,132 | $832.00 | 39.0% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 14 | 14 | $1,558 | $562.51 | 36.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 88 | 104 | $25,272 | $7,002 | 27.7% |
| 22612 | Fusion of lower spine bones, posterior or posterolateral approach | Facility | 2020 | 27 | 27 | $19,926 | $3,998 | 20.1% |
| 22614 | Fusion of spine bones, posterior or posterolateral approach | Facility | 2020 | 20 | 51 | $9,333 | $1,931 | 20.7% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 18 | 18 | $6,696 | $1,687 | 25.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 35 | 36 | $6,840 | $1,666 | 24.3% |
| 72110 | X-ray of lower and sacral spine, minimum of 4 views | Office | 2020 | 57 | 58 | $7,763 | $1,624 | 20.9% |
| 63047 | Partial removal of middle spine bone with release of spinal cord and/or nerves | Facility | 2020 | 19 | 19 | $16,416 | $1,601 | 9.8% |
| 22842 | Insertion of posterior spinal instrumentation for spinal stabilization, 3 to 6 vertebral segments | Facility | 2020 | 16 | 16 | $5,712 | $1,151 | 20.1% |
| 22558 | Fusion of spine bones with removal of disc at lower spinal column, anterior approach | Facility | 2020 | 12 | 12 | $8,556 | $1,083 | 12.7% |
| 72100 | X-ray of lower and sacral spine, 2 or 3 views | Office | 2020 | 33 | 36 | $3,060 | $751.08 | 24.5% |
| 72050 | X-ray of upper spine, 4 or 5 views | Office | 2020 | 23 | 23 | $2,346 | $723.93 | 30.9% |
| 22853 | Insertion of device into intervertebral disc space of spine and fusion of vertebrae | Facility | 2020 | 17 | 29 | $3,973 | $672.88 | 16.9% |
| 63048 | Partial removal of spine bone with release of spinal cord and/or nerves | Facility | 2020 | 13 | 27 | $3,213 | $573.71 | 17.9% |
| 72040 | X-ray of spine of neck, 2 or 3 views | Office | 2020 | 15 | 21 | $1,575 | $468.96 | 29.8% |
About Gary Hurst, ARNP
Gary Hurst, ARNP is a Nurse Practitioner healthcare provider based in Post Falls, Idaho. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1114951647.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Gary Hurst, ARNP has received a total of $1,408 in payments from pharmaceutical and medical device companies, with $523.88 received in 2024. These payments were reported across 72 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($1,408).
As a Medicare-enrolled provider, Hurst has provided services to 715 Medicare beneficiaries, totaling 817 services with total Medicare billing of $53,329. Data is available for 4 years (2020–2023), covering 27 distinct procedure/service records.
Ad
Practice Information
- Specialty Nurse Practitioner
- Other Specialties Family, Registered Nurse
- Location Post Falls, ID
- Active Since 07/10/2006
- Last Updated 01/28/2021
- Taxonomy Code 363L00000X
- Entity Type Individual
- NPI Number 1114951647
Products in Payments
- ZEPOSIA (Drug) $577.99
- MAVENCLAD (Drug) $203.85
- TYSABRI (Biological) $52.96
- GENERAL PAIN MANAGEMENT (Device) $43.46
- Enspryng (Biological) $42.42
- BAFIERTAM (Drug) $28.56
- KESIMPTA (Drug) $28.10
- ULTOMIRIS (Biological) $24.84
- AUBAGIO (Drug) $24.75
- StimQ Receiver Stimulator Kit Channel A US w Receiver (Device) $23.21
- MAYZENT (Drug) $21.75
- BRIUMVI (Drug) $21.65
- SOLIRIS (Biological) $21.31
- EVUSHELD (Drug) $19.59
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Nurse Practitioner Doctors in Post Falls
Jennifer Torok, Arnp, ARNP
Nurse Practitioner — Payments: $3,370
Nurse Practitioner $3,370
Colleen Graey, Fnp, FNP
Nurse Practitioner — Payments: $1,187
Nurse Practitioner $1,187
Mrs. Shauna Spellman, Arnp, ARNP
Nurse Practitioner — Payments: $1,007
Nurse Practitioner $1,007
Mary Liter, Arnp, ARNP
Nurse Practitioner — Payments: $760.76
Nurse Practitioner $760.76
Mrs. Laura Ensley-Eddy, M.s.n., F.n.p.-C, M.S.N., F.N.P.-C
Nurse Practitioner — Payments: $689.46
Nurse Practitioner $689.46
Barbara Richardson, Arnp, ARNP
Nurse Practitioner — Payments: $216.45
Nurse Practitioner $216.45